http://purl.uniprot.org/citations/18784072 | http://www.w3.org/1999/02/22-rdf-syntax-ns#type | http://purl.uniprot.org/core/Journal_Citation |
http://purl.uniprot.org/citations/18784072 | http://www.w3.org/2000/01/rdf-schema#comment | "Hepsin, a cell surface protease, is widely reported to be overexpressed in more than 90% of human prostate tumors. Hepsin expression correlates with tumor progression, making it a significant marker and target for prostate cancer. Recently, it was reported that in a prostate cancer mouse model, hepsin up-regulation in tumor tissue promotes progression and metastasis. The underlying mechanisms, however, remain largely uncharacterized. Hepsin transgenic mice displayed reduced laminin-332 (Ln-332) expression in prostate tumors. This is an intriguing cue, since proteolytic processing of extracellular matrix macromolecules, such as Ln-332, is believed to be involved in cancer progression, and Ln-332 expression is lost during human prostate cancer progression. In this study, we provide the first direct evidence that hepsin cleaves Ln-332. Cleavage is specific, since it is both inhibited in a dose-dependent manner by a hepsin inhibitor (Kunitz domain-1) and does not occur when catalytically inactive hepsin is used. By Western blotting and mass spectrometry, we determined that hepsin cleaves the beta3 chain of Ln-332. N-terminal sequencing identified the cleavage site at beta3 Arg(245), in a sequence context (SQLR(245) LQGSCFC) conserved among species and in remarkable agreement with reported consensus target sequences for hepsin activity. In vitro cell migration assays showed that hepsin-cleaved Ln-332 enhanced motility of DU145 prostate cancer cells, which was inhibited by Kunitz domain-1. Further, hepsin-overexpressing LNCaP prostate cancer cells also exhibited increased migration on Ln-332. Direct cleavage of Ln-332 may be one mechanism by which hepsin promotes prostate tumor progression and metastasis, possibly by up-regulating prostate cancer cell motility."xsd:string |
http://purl.uniprot.org/citations/18784072 | http://purl.org/dc/terms/identifier | "doi:10.1074/jbc.m802312200"xsd:string |
http://purl.uniprot.org/citations/18784072 | http://purl.uniprot.org/core/author | "Yamashita H."xsd:string |
http://purl.uniprot.org/citations/18784072 | http://purl.uniprot.org/core/author | "Ganesan R."xsd:string |
http://purl.uniprot.org/citations/18784072 | http://purl.uniprot.org/core/author | "Quaranta V."xsd:string |
http://purl.uniprot.org/citations/18784072 | http://purl.uniprot.org/core/author | "Kirchhofer D."xsd:string |
http://purl.uniprot.org/citations/18784072 | http://purl.uniprot.org/core/author | "Tripathi M."xsd:string |
http://purl.uniprot.org/citations/18784072 | http://purl.uniprot.org/core/author | "Nandana S."xsd:string |
http://purl.uniprot.org/citations/18784072 | http://purl.uniprot.org/core/date | "2008"xsd:gYear |
http://purl.uniprot.org/citations/18784072 | http://purl.uniprot.org/core/name | "J Biol Chem"xsd:string |
http://purl.uniprot.org/citations/18784072 | http://purl.uniprot.org/core/pages | "30576-30584"xsd:string |
http://purl.uniprot.org/citations/18784072 | http://purl.uniprot.org/core/title | "Laminin-332 is a substrate for hepsin, a protease associated with prostate cancer progression."xsd:string |
http://purl.uniprot.org/citations/18784072 | http://purl.uniprot.org/core/volume | "283"xsd:string |
http://purl.uniprot.org/citations/18784072 | http://www.w3.org/2004/02/skos/core#exactMatch | http://purl.uniprot.org/pubmed/18784072 |
http://purl.uniprot.org/citations/18784072 | http://xmlns.com/foaf/0.1/primaryTopicOf | https://pubmed.ncbi.nlm.nih.gov/18784072 |
http://purl.uniprot.org/uniprot/#_A0A140VJK9-mappedCitation-18784072 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/18784072 |
http://purl.uniprot.org/uniprot/#_E9Q5P0-mappedCitation-18784072 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/18784072 |
http://purl.uniprot.org/uniprot/#_B7Z1L4-mappedCitation-18784072 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/18784072 |
http://purl.uniprot.org/uniprot/#_B2ZDQ2-mappedCitation-18784072 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/18784072 |
http://purl.uniprot.org/uniprot/#_O35453-mappedCitation-18784072 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/18784072 |
http://purl.uniprot.org/uniprot/#_G3UWE8-mappedCitation-18784072 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/18784072 |
http://purl.uniprot.org/uniprot/#_Q3U0U6-mappedCitation-18784072 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/18784072 |
http://purl.uniprot.org/uniprot/#_L8E9T7-mappedCitation-18784072 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/18784072 |
http://purl.uniprot.org/uniprot/#_P05981-mappedCitation-18784072 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/18784072 |